An Argentinian court has begun hearing a second criminal trial concerning the medical treatment provided to football legend Diego Maradona before his death in November 2020. Prosecutors allege that physicians overseeing Maradona’s home hospitalization failed to recognize and act on clear clinical indicators of kidney failure, a lapse they argue constitutes criminal negligence. The proceedings mark a new phase in a case that has drawn intense public scrutiny in Argentina and abroad, focusing on whether the standard of care provided to one of sport’s most iconic figures fell below legal and professional thresholds.
What Happened
The trial, which opened in a Buenos Aires courtroom, centers on the actions of Maradona’s medical team during the weeks leading up to his death on November 25, 2020. According to legal arguments presented to the court, laboratory results and clinical observations available to the treating physicians showed “red flag” warning signs of renal deterioration. Prosecutors contend that these indicators — which may have included elevated creatinine levels, reduced urine output, and electrolyte imbalances — were either overlooked or not acted upon with the urgency required by Maradona’s complex medical history.
The defendants include neurosurgeon Leopoldo Luque and psychiatrist Agustina Cosachov, who were the primary architects of Maradona’s home-based care plan following his brain surgery in early November 2020. Both have denied wrongdoing. The court is examining whether the medical team’s failure to escalate care, order further diagnostics, or transfer Maradona to a hospital setting when renal markers worsened constitutes a breach of duty that contributed to his death from cardiac arrest.
Witness testimony is expected to include forensic medical experts who will reconstruct the timeline of Maradona’s vital signs and lab results in his final days. The prosecution’s case rests on establishing that the renal warning signs were objectively present in the medical record and that a competent physician would have intervened. The defense is expected to argue that Maradona’s overall clinical picture was complicated by multiple comorbidities, patient non-compliance, and the inherent difficulties of managing a high-profile patient in a non-hospital environment.
Why It Matters
The trial carries significance beyond the specific facts of Maradona’s death. It tests the Argentine legal system’s capacity to hold medical professionals criminally accountable for clinical decisions made in home-care settings — a growing area of practice worldwide. The case also raises questions about the intersection of celebrity, medical ethics, and institutional oversight when a patient’s fame may influence the behavior of their care team.
For the Argentine public, Maradona remains a figure of near-mythic stature. His death triggered national mourning and widespread anger over the circumstances of his final weeks. The first trial, which concluded with convictions for some members of the medical team on charges of “simple homicide with eventual intent,” established a precedent for criminal liability in medical negligence cases. This second trial, focused specifically on renal management, seeks to deepen that accountability by isolating a discrete physiological failure pathway.
Internationally, the case is being watched by legal scholars and medical ethicists as a rare instance of criminal prosecution for alleged medical negligence in a home-hospitalization context. Most jurisdictions handle such matters through civil malpractice suits or professional disciplinary boards. Argentina’s use of criminal law reflects a distinct legal philosophy regarding the protection of vulnerable patients.
Analysis:
The prosecution’s focus on renal failure represents a strategic narrowing of the case. By homing in on a specific organ system with measurable biomarkers, prosecutors avoid the more diffuse arguments about overall quality of care that can be harder to prove beyond reasonable doubt. Renal function is tracked through objective laboratory values — creatinine, blood urea nitrogen, glomerular filtration rate — that leave a documentary trail. If the medical record shows a clear trend of worsening renal markers without corresponding clinical action, the evidentiary burden shifts to the defense to explain why those values did not trigger intervention.
This approach also reflects an understanding of Maradona’s medical history. The former footballer had a long-documented history of substance use, cardiovascular disease, and prior kidney stress. In such a patient, renal function is a sentinel indicator; its decline often precedes multi-organ failure. A competent internist or nephrologist would treat rising creatinine in this context as a medical emergency requiring immediate hospitalization, intravenous hydration, medication review, and possibly dialysis. The allegation is not that the doctors caused the kidney failure, but that they failed to respond to it — a distinction that aligns with the legal concept of omission rather than commission.
Background and Context
Diego Maradona died at age 60 in a rented house in Tigre, a suburb of Buenos Aires, where he was recovering from surgery to remove a subdural hematoma performed on November 3, 2020. The operation, conducted by Luque, was deemed successful. However, Maradona’s post-operative care was managed at home rather than in a rehabilitation facility or hospital — a decision that has been central to the controversy.
The home care arrangement was authorized by Maradona’s family and overseen by a team that included nurses, a therapeutic companion, and the two lead physicians. From the outset, concerns were raised about the adequacy of the setup: the house lacked intensive care equipment, the nursing staff were not specialized in critical care, and Maradona’s own adherence to medication and dietary restrictions was inconsistent.
In 2021, a medical board convened by the prosecutor’s office concluded that Maradona’s care was “deficient” and “reckless,” and that he would have had a better chance of survival in a proper medical facility. That report formed the basis of the first trial, which resulted in 2024 convictions for several members of the care team. Luque and Cosachov were among those found guilty of “simple homicide with eventual intent” — a charge that applies when a person foresees the possibility of death resulting from their actions or omissions and proceeds regardless. They received prison sentences, though appeals are pending.
The current trial appears to be a supplementary proceeding, possibly initiated after the medical board’s report highlighted renal management as a specific area of failure not fully adjudicated in the first trial. Argentine procedural law allows for separate trials when distinct criminal acts or omissions are identified in the same overall episode.
Analysis:
The decision to pursue a second trial on renal-specific allegations suggests prosecutors believe the evidence on this point is particularly strong — or that the first trial’s verdict left a gap in accountability for the physiological cascade that directly led to cardiac arrest. Renal failure causes hyperkalemia (elevated potassium), which is a well-known trigger for fatal arrhythmias. If Maradona’s potassium levels were rising in his final days and were not checked or treated, the causal chain from omission to death becomes medically and legally coherent.
It is also possible that the second trial reflects a strategic choice by prosecutors to secure convictions on the clearest possible grounds. The first trial’s “eventual intent” standard requires proving the doctors foresaw the risk of death. That is a high bar. A narrower focus on failure to act on specific lab values may allow a conviction on a lesser charge, such as “culpable homicide” (negligent homicide), which requires only a breach of the duty of care — a more straightforward showing in a medical context.
What to Watch Next
Several developments will shape the trial’s trajectory and its broader impact:
Expert testimony: The credibility and independence of the forensic medical experts will be pivotal. The court has appointed its own experts, but both sides will present their own. Disagreements over the interpretation of lab trends, the significance of specific creatinine thresholds, and the feasibility of intervention in a home setting will dominate the evidentiary phase.
Nursing records: The daily logs kept by the home nursing staff may provide a real-time account of Maradona’s urine output, mental status, edema, and complaints — all relevant to renal assessment. If those records show documented deterioration without physician notification, the case for negligence strengthens. If they are incomplete or missing, the defense may argue that the doctors were not adequately informed.
Communications evidence: WhatsApp messages, emails, and phone records among the medical team, the family, and the clinic that employed them have been seized. These may reveal whether renal concerns were discussed, dismissed, or escalated. In the first trial, such communications were damaging to the defense, showing awareness of Maradona’s fragility and debates over hospital transfer.
Appellate outcomes
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: Al Jazeera News — source
